MCMANUS MICHAEL A JR

Average Profitability
12.15%
Insider Buys Quantity
8
Insider Buys Sum
$579,034.55
Insider Sells Quantity
3
Insider Sells Sum
$3.25M

Insider Activity of MCMANUS MICHAEL A JR

According to the SEC Form 4 filings, MCMANUS MICHAEL A JR, being in a position of

  1. director at United States Antimony Corporation,
    оver the last 12 months, has bought 135000 shares for $51,705, and sold 0 shares,
    over all time since 2024-08-14, has bought 135000 shares for $51,705, and sold 0 shares.

The largest purchase of all time was on 2017-05-19 and amounted to 10000 shares of The Eastern Company for $259,000.

The largest sale of all time was on 2020-08-18 and amounted to 16000 shares of Novavax, Inc. for $2.34M.

Biography of MCMANUS MICHAEL A JR

No biography is available at this moment.

2024-08-14PurchaseUnited States Antimony Corporation
UAMY
director
135,000
0.1285%
$0.38$51,7050%
2021-03-19SaleNovavax, Inc.
NVAX
director
4,000
0.0053%
$220.78$883,110-21.79%
2020-08-18SaleNovavax, Inc.
NVAX
director
16,000
0.026%
$146.00$2.34M+3.14%
2019-11-18SaleNovavax, Inc.
NVAX
director
7,858
0.0325%
$3.82$30,029+1,069.45%
2017-05-19PurchaseThe Eastern Company
EML
director
10,000
0.1429%
$25.90$259,000-1.43%
2017-05-12PurchaseNovavax, Inc.
NVAX
director
40,000
0.0137%
$0.97$38,792+19%
2017-05-11PurchaseNovavax, Inc.
NVAX
director
20,000
0.0064%
$0.84$16,800+27.96%
2016-09-21PurchaseNovavax, Inc.
NVAX
director
60,000
0.0184%
$1.61$96,594-34.54%
2008-07-31PurchaseNovavax, Inc.
NVAX
director
17,590
0.0299%
$2.85$50,044-19.84%
2005-09-01PurchaseNovavax, Inc.
NVAX
director
20,000
0.0508%
$1.60$32,000+192.07%
2004-08-16PurchaseNovavax, Inc.
NVAX
director
10,000
0.0265%
$3.41$34,100-30.33%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.